These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7110114)

  • 1. beta-Diethylaminoethyl-2, 2-diphenylpentanoate (SKF 525-A)-mediated translocation of uterine estrogen receptor from the cytosolic to the nuclear compartment in isolated rat uteri.
    Bulger WH; Kupfer D
    Mol Pharmacol; 1982 May; 21(3):533-7. PubMed ID: 7110114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid receptor forms and their interaction with cytoplasmic modulators.
    Sato B; Nishizawa Y; Maeda Y; Noma K; Honma T; Matsumoto K
    J Steroid Biochem; 1983 Jul; 19(1A):315-21. PubMed ID: 6887866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of hepatic monooxygenases in generating estrogenic metabolites from methoxychlor and from its identified contaminants.
    Bulger WH; Feil VJ; Kupfer D
    Mol Pharmacol; 1985 Jan; 27(1):115-24. PubMed ID: 3965923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen action in the mouse uterus: the influence of the neuroendocrine-adrenal axis.
    Quarmby VE; Fox-Davies C; Korach KS
    Endocrinology; 1984 Jan; 114(1):108-15. PubMed ID: 6690267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen action in the mouse uterus: adrenal modulation of receptor levels.
    Quarmby VE; Fox-Davies C; Swaisgood MH; Korach KS
    Endocrinology; 1982 Apr; 110(4):1208-16. PubMed ID: 7060522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.
    Markaverich BM; Roberts RR; Alejandro MA; Clark JH
    Cancer Res; 1984 Apr; 44(4):1515-9. PubMed ID: 6704964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of rotenone to interfere with 17 beta-estradiol action in the rat uterus.
    Olson ME; Sheehan DM
    Cancer Res; 1979 Nov; 39(11):4438-40. PubMed ID: 498075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative analysis of the interaction of various estrogens with the estrogen-receptor system of the uterus].
    Fanchenko ND; Alekseeva ML; Minina LS; Novikov EA; Khel'mun DK
    Biokhimiia; 1985 Nov; 50(11):1853-8. PubMed ID: 4063405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose dependent modulation of receptor dynamics and uterine growth in immature rat by estradiol: importance of an additional nuclear binding at 24 hr for long-term (72 hr) uterine growth.
    Agarwal AK; Durani S; Setty BS
    Endokrinologie; 1982 Jun; 79(2):235-41. PubMed ID: 7128542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic estrogen responsiveness. Possible mechanisms for sexual dimorphism.
    Thompson C; Lucier GW
    Mol Pharmacol; 1983 Jul; 24(1):69-76. PubMed ID: 6865928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrone receptor formation during the processing of estradiol-receptor complex in MCF-7 cells.
    Hansen ER; Brooks SC
    Cancer Res; 1982 May; 42(5):1967-74. PubMed ID: 7066908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a unique population of unfilled estrogen-binding sites associated with the nuclear fraction of immature rat uteri.
    Carlson RA; Gorski J
    Endocrinology; 1980 Jun; 106(6):1776-85. PubMed ID: 7371593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDRI-85/287: studies on competition to estrogen binding sites in the immature rat uterus.
    Sreenivasulu S; Dwivedi A; Singh MM; Setty BS; Kamboj VP
    Indian J Exp Biol; 1992 Dec; 30(12):1115-7. PubMed ID: 1294475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile.
    Gallo D; Zannoni GF; Apollonio P; Martinelli E; Ferlini C; Passetti G; Riva A; Morazzoni P; Bombardelli E; Scambia G
    Menopause; 2005; 12(5):589-600. PubMed ID: 16145313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a unique nuclear estrogen-binding component in an estrogen-responsive mouse Leydig cell tumor.
    Maeda Y; Sato B; Noma K; Kishimoto S; Koizumi K; Aono T; Matsumoto K
    Cancer Res; 1983 Sep; 43(9):4091-7. PubMed ID: 6871850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear interaction of Fusarium mycotoxins with estradiol binding sites in the mouse uterus.
    Greenman DL; Mehta RG; Wittliff JL
    J Toxicol Environ Health; 1979 Jul; 5(4):593-8. PubMed ID: 490675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17 Alpha-ethinyl estradiol is more potent than estradiol in receptor interactions with isolated hepatic parenchymal cells.
    Dickson RB; Eisenfeld AJ
    Endocrinology; 1981 Apr; 108(4):1511-8. PubMed ID: 7472281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of estrogen action during preimplantation period and in immature estradiol-primed rat uterus by anti-implantation agent, ormeloxifene.
    Dwivedi A; Basu R; Chowdhury SR; Goyal N
    Contraception; 2005 Jun; 71(6):458-64. PubMed ID: 15914137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear binding of the estrogen receptor: heterogeneity of sites and uterotropic response.
    Clark JH; Markaverich B; Upchurch S; Eriksson H; Hardin JW
    Adv Exp Med Biol; 1979; 117():17-46. PubMed ID: 474276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marijuana: interaction with the estrogen receptor.
    Sauer MA; Rifka SM; Hawks RL; Cutler GB; Loriaux DL
    J Pharmacol Exp Ther; 1983 Feb; 224(2):404-7. PubMed ID: 6296360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.